• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Cosmetics
  • Measures for Cosmetics Adverse Reaction Monitoring Coming Into Effect on October 1, 2022

Measures for Cosmetics Adverse Reaction Monitoring Coming Into Effect on October 1, 2022

Measures for Cosmetics Adverse Reaction
Friday, 25 March 2022 / Published in Cosmetics, News, NMPA Registration in China

Measures for Cosmetics Adverse Reaction Monitoring Coming Into Effect on October 1, 2022

Measures for cosmetics adverse reaction monitoring was issued (No.16-2022) on February 21, 2022 by the NMPA (National Medical Products Administration) as the finalized regulatory measure for monitoring the adverse reactions of cosmetics in China. The measure was written in accordance to the new Cosmetics Administration and Supervision Regulations (CSAR), and will come into effect on October 1, 2022.

Highlights – Measures for cosmetics adverse reaction monitoring

  • The regulatory document consists of 7 chapters and 47 articles covering general provisions, duties and obligations for adverse reaction reporting, adverse reaction analysis and evaluation, adverse reaction investigation, etc.
  • Overseas registrants and filers should establish a system with their domestic responsible person for collecting and carrying out evaluation, reports and investigations on adverse reactions.
  • Adverse reactions are classified into three levels: General, Serious, and Great Impact to the Community. There are corresponding regulatory measures to be carried out for each different levels of classification.
  • Adverse reaction monitoring plays an important role in post-market risk warning, and this regulatory measure aims to enhance the level of risk prevention and control effectively.

By Jeff Jiang. Contact Cisema if you would like to learn more.

Tagged under: Adverse Events, cosmetics

What you can read next

CCC regulation CNCA-C22-01:2020 and CNCA-C22-02:2020 published
Medical Device Electronic Submission System (eRPS)
Successful Project Launch of Chery Jaguar Land Rover (CJLR)

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China medical device sampling inspection results

    China medical device sampling inspection results no.4 of 2022

    China medical device sampling inspection result...
  • NMPA cosmetic sampling inspection

    The NMPA Cosmetic Sampling Inspection measures come into force on March 1, 2023

    NMPA Cosmetic Sampling Inspection Measures come...
  • China cosmetics quality safety responsibilities

    China cosmetics quality and safety responsibilities regulations released

    China cosmetics quality and safety responsibili...
  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.